ITRUSDI
DEAD

Serial Number

97091235

Owner

H. Lundbeck A/S

Attorney

Alexander Reid

Filing Date

Oct 25, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ITRUSDI Trademark

Serial Number: 97091235

ITRUSDI is a trademark filed by H. Lundbeck A/S on October 25, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

H. Lundbeck A/S (398 trademarks)

Ottiliavej 9
DK-2500 Copenhagen-Valby , DK

Entity Type: 03

Trademark Details

Filing Date

October 25, 2021

Registration Date

Not Registered

Goods & Services

Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes

Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, monitoring, assessing, controlling, collecting, storing and examining patient and client data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems

Filing History

ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Jan 19, 2023 MAB1
ABANDONMENT - EXPRESS MAILED
Jan 19, 2023 ABN1
TEAS EXPRESS ABANDONMENT RECEIVED
Jan 18, 2023 EXAR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 6, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 6, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jul 6, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 10, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2021 NWOS
NEW APPLICATION ENTERED
Oct 28, 2021 NWAP